Tweet Disematkan

Welcome to the ENOS-2 trial!
Managed by @UoN_STU
Sponsored by @MedicineUoN
Funded by @NUHCharity
Delivered by @UoN_StrokeRes
NIHR Portfolio study @NIHRresearch
English
ENOS-2
50 posts

@ENOS2Trial
Randomised trial assessing the feasibility of recruitment & safety of transdermal GTN vs sham applied between 3-5 hours of stroke to inform a definitive trial.

























Congratulations to Prof. Philip Bath, recipient of the prestigious ESO Presidential Award, and Dr. Jonathan Coutinho, honored with the ESO Scientific Excellence Award at #ESOC2023. Join us in celebrating the award recipients for their exceptional contributions to #strokeresearch.






